Pathogen inactivation: making decisions about new technologies

This publication has 75 references indexed in Scilit:

• Transfusion-transmitted infections
  Journal of Translational Medicine, 2007
• Quality and safety of fresh‐frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years’ experience
  Vox Sanguinis, 2007
• Confidentiality Laws And Secrecy In Medical Research: Improving Public Access To Data On Drug Safety
  Health Affairs, 2007
• Emerging Infectious Diseases That Threaten the Blood Supply
  Seminars in Hematology, 2007
• End‐to‐end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses
  Transfusion, 2006
• Self‐reported symptoms associated with West Nile virus infection in RNA‐positive blood donors
  Transfusion, 2005
• Medicines regulation and the pharmaceutical industry
  BMJ, 2005
• Cost‐effectiveness of pathogen inactivation for platelet transfusions in the Netherlands
  Transfusion Medicine, 2005
• Threats to blood safety posed by emerging protozoan pathogens
  Vox Sanguinis, 2004
• The Role of Cost-Consequence Analysis in Healthcare Decision-Making
  PharmacoEconomics, 1998